Start Date
4-16-2024 4:45 PM
End Date
4-16-2024 5:30 PM
Description
Abstract
The current biomarkers used for detecting renal disease Creatinine has long been seen to be inadequate in identifying the extent of renal disease in African and African American populations. CB1 and CB2 receptors are ubiquitous in the human body and their expression is increased with inflammation in the body. In response to the increased expression, the hypothalamus produces endocannabinoids in response. As a result, endocannabinoids can be a biomarker in detecting renal disease where inflammation is a significant factor in renal injury.
Included in
Endocannabinoids and their Role in Renal Health of African Americans
Abstract
The current biomarkers used for detecting renal disease Creatinine has long been seen to be inadequate in identifying the extent of renal disease in African and African American populations. CB1 and CB2 receptors are ubiquitous in the human body and their expression is increased with inflammation in the body. In response to the increased expression, the hypothalamus produces endocannabinoids in response. As a result, endocannabinoids can be a biomarker in detecting renal disease where inflammation is a significant factor in renal injury.
